SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-21-000006
Filing Date
2021-02-26
Accepted
2021-02-26 16:14:59
Documents
15
Period of Report
2021-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K bbi-20210222.htm   iXBRL 8-K 33386
7 bbi-20210222_g1.jpg GRAPHIC 6568
  Complete submission text file 0000819050-21-000006.txt   196685

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20210222.xsd EX-101.SCH 2428
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbi-20210222_cal.xml EX-101.CAL 719
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbi-20210222_def.xml EX-101.DEF 1656
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20210222_lab.xml EX-101.LAB 25298
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20210222_pre.xml EX-101.PRE 13199
8 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20210222_htm.xml XML 11199
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 21688961
SIC: 2836 Biological Products, (No Diagnostic Substances)